Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment.

The Journal of dermatological treatment - 1 Dec 2024

Lochbaum Robin, Trainotti Susanne, Hoffmann Thomas K, Greve Jens, Hahn Janina

Abstract excerpt

BACKGROUND: Hereditary angioedema with normal C1-inhibitor (HAE-nC1-INH) is a rare genetic disease. The symptoms can resemble other forms of hereditary angioedema (HAE), but the specific laboratory values are inconspicuous. The knowledge about treatment strategies in HAE-nC1-INH remains insufficient; most of the drugs are only licensed and approved for other types of HAE. METHODS: An analysis of all patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angioedemas, Hereditary
Share to Factor XII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Plasminogen

Source

Identifiers

PMID: 38086754
DOI: 10.1080/09546634.2023.2290362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment.PMID 38086754Read ↗

Hereditary and acquired angioedema.Semantic proximity Read ↗

Hereditary angioedema with normal C1-inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families.Semantic proximity Read ↗

Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.Semantic proximity Read ↗

Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.Semantic proximity Read ↗

[Diagnosis and treatment of hereditary angioedema with normal C1-inhibitor level].Semantic proximity Read ↗

Real-World Evidence on the Management of Hereditary Angioedema With Normal C1 Inhibitor.Semantic proximity Read ↗

Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.Semantic proximity Read ↗

Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort.Semantic proximity Read ↗

Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.Semantic proximity Read ↗

Hereditary AngioedemaSemantic proximity Read ↗

Diagnosis and treatment of hereditary angioedema.Semantic proximity Read ↗

Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.